证券代码：300165 证券简称：ST天瑞 公告编号：2025-044 江苏天瑞仪器股份有限公司 关于公司股票被实施其他风险警示相关事项的进展公告 1、江苏天瑞仪器股份有限公司（以下简称"公司"）收到中国证监会出具的 《行政处罚事先告知书》并于2024年12月9日披露了《关于公司及相关当事人收 到<行政处罚事先告知书>的公告》（公告编号：2024-073）。根据《深圳证券交 易所创业板股票上市规则》第9.4条第（七）项规定，公司股票于2024年12月10 日起被实施其他风险警示。 2、公司于2025年3月18日收到中国证监会出具的《行政处罚决定书》 （[2025]40号），公司收到的《行政处罚决定书》中认定的情况与《行政处罚事 先告知书》中涉及的违法违规行为一致。 3、根据《深圳证券交易所创业板股票上市规则》第9.9条规定，公司因触及 第9.4条第七项情形，其股票交易被实施其他风险警示期间，应当至少每月披露一 次差错更正进展公告，直至披露行政处罚决定所涉事项财务会计报告更正公告及 会计师事务所出具的专项核查意见等文件。 一、实施其他风险警示的原因 公司于2024年12月6日收到中国证监会出具的《行政处罚事先告 ...

证券之星消息，根据天眼查APP-财产线索数据整理，根据金华市计量质量科学研究院月9日16发布的 《浙江金华阳光招标代理有限公司关于金华市计量质量科学研究院X射线荧光光谱分析仪采购项目（非 政府采购）的中标结果公告》内容显示，江苏天瑞仪器股份有限公司中标，详情如下： 标题：浙江金华阳光招标代理有限公司关于金华市计量质量科学研究院X射线荧光光谱分析仪采购项目 （非政府采购）的中标结果公告 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 采购方：金华市计量质量科学研究院 供应商：江苏天瑞仪器股份有限公司 中标金额：165000.0 地区：浙江省 发布日期：2025-09-16 通过天眼查大数据分析，江苏天瑞仪器股份有限公司共对外投资了23家企业，参与招投标项目928次； 财产线索方面有商标信息48条，专利信息665条，著作权信息143条；此外企业还拥有行政许可34个。 数据来源：天眼查APP ...

上海市广发律师事务所 关于江苏天瑞仪器股份有限公司 2025 年第二次临时股东大会的法律意见书 致：江苏天瑞仪器股份有限公司 江苏天瑞仪器股份有限公司（以下简称"公司"）2025 年第二次临时股东 大会于 2025 年 9 月 12 日在江苏省昆山市中华园西路 1888 号天瑞大厦会议室召 开。上海市广发律师事务所经公司聘请，委派汤颖律师、占新越律师出席现场会 议，根据《中华人民共和国公司法》（以下简称"《公司法》"）、《上市公司 股东会规则》（以下简称"《股东会规则》"）等法律法规、其他规范性文件以 及《江苏天瑞仪器股份有限公司章程》（以下简称"《公司章程》"）的规定， 就本次股东大会的召集和召开程序、召集人及出席会议人员的资格、会议议案、 表决方式和表决程序、表决结果和会议决议等出具本法律意见书。 本次股东大会是由公司董事会根据 2025 年 8 月 25 日召开的第六届董事会第 十六次会议决议召集。公司已于 2025 年 8 月 27 日在深圳证券交易所指定网站及 相关指定媒体上刊登了《江苏天瑞仪器股份有限公司关于召开 2025 年第二次临 时股东大会的通知》，并决定采取现场会议表决和网络投票相结合的方 ...

证券代码：300165 证券简称：ST天瑞 公告编号：2025-043 江苏天瑞仪器股份有限公司 关于选举第六届董事会职工代表董事的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 江苏天瑞仪器股份有限公司董事会 二○二五年九月十二日 附件：贾立图女士简历 根据《中华人民共和国公司法》《深圳证券交易所创业板股票上市规则》《深 圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等 法律法规、规范性文件及《公司章程》的有关规定，江苏天瑞仪器股份有限公 司（以下简称"公司"）于 2025 年 9 月 12 日召开了职工代表大会，经与会职工 代表审议，会议同意选举贾立图女士为公司第六届董事会职工代表董事（简历 详见附件）。贾立图女士由第六届董事会非独立董事变更为第六届董事会职工代 表董事，任期至第六届董事会任期届满之日。 本次选举完成后，公司董事会中兼任公司高级管理人员以及由职工代表担任 的董事人数总计未超过公司董事总数的二分之一，符合相关法律法规及《公司章 程》等的规定。 特此公告。 贾立图女士：中国国籍，无境外居留权，1980 年 1 月生 ...

证券代码：300165 证券简称：ST天瑞 公告编号：2025-042 江苏天瑞仪器股份有限公司 2025 年第二次临时股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会未出现否决议案的情形。 （1）现场会议时间：2025 年 9 月 12 日（星期五）下午 15:00 （2）网络投票时间： ①通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 9 月 12 日 9:15-9:25，9:30-11:30 和 13:00-15:00； ②通过深圳证券交易所互联网投票系统进行网络投票的具体时间为：2025 年 9 月 12 日 9:15 至 15:00 期间的任意时间。 2、现场会议召开地点：昆山市玉山镇中华园西路 1888 号天瑞大厦八楼会 议室。 3、会议召开方式：本次股东大会采取网络投票和现场表决相结合的方式召 开。 2、本次股东大会不涉及变更以往股东大会已通过的决议。 一、会议召开和出席情况 （一）会议召开情况 1、会议召开的时间： 4、会议召集人：公司董事会 5、会议主持人：董事长刘召贵先生 6、 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 二、采取的措施及进展情况 特别提示： 1、江苏天瑞仪器股份有限公司（以下简称"公司"）收到中国证监会出具的 《行政处罚事先告知书》并于2024年12月9日披露了《关于公司及相关当事人收 到<行政处罚事先告知书>的公告》（公告编号：2024-073）。根据《深圳证券交 易所创业板股票上市规则》第9.4条第（七）项规定，公司股票于2024年12月10 日起被实施其他风险警示。 2、公司于2025年3月18日收到中国证监会出具的《行政处罚决定书》 （[2025]40号），公司收到的《行政处罚决定书》中认定的情况与《行政处罚事 先告知书》中涉及的违法违规行为一致。 3、根据《深圳证券交易所创业板股票上市规则》第9.9条规定，公司因触及 第9.4条第七项情形，其股票交易被实施其他风险警示期间，应当至少每月披露一 次差错更正进展公告，直至披露行政处罚决定所涉事项财务会计报告更正公告及 会计师事务所出具的专项核查意见等文件。 一、实施其他风险警示的原因 公司于2024年12月6日收到中国证监会出具的《行政处罚事先告知书》，根据 ...

Group 1 - The core viewpoint of the article highlights the financial performance of ST Tianrui, indicating a significant decline in revenue and a negative net profit for the first half of 2025 [1] - The total operating revenue for the reporting period was 295 million yuan, a year-on-year decrease of 22.36%, while the net profit attributable to shareholders was -9.58 million yuan, an increase of 35.63% year-on-year [1] - In Q2, the operating revenue was 166 million yuan, down 31.63% year-on-year, and the net profit attributable to shareholders was -12.75 million yuan, a decline of 98.85% year-on-year [1] Group 2 - The company has a large amount of accounts receivable, with accounts receivable accounting for 53.46% of the total operating revenue in the latest annual report [1] - The gross profit margin was 44.76%, an increase of 10.44% year-on-year, while the net profit margin was -6.55%, a decrease of 83.28% year-on-year [1] - Total selling, administrative, and financial expenses amounted to 85.69 million yuan, representing 29.07% of revenue, an increase of 13.52% year-on-year [1] Group 3 - The company’s historical financial performance has been generally poor, with a median ROIC of 0.98% over the past decade and a particularly low ROIC of -5.33% in 2024 [2] - The business model relies heavily on marketing-driven performance, necessitating a thorough examination of the underlying drivers [2] - The company has reported four years of losses since its listing, indicating a lack of consistent profitability [2] Group 4 - The cash flow situation is concerning, with cash and cash equivalents accounting for only 3.07% of total assets and 18.6% of current liabilities [3] - The debt situation is also alarming, with an interest-bearing asset liability ratio of 37.9% and negative average operating cash flow over the past three years [3] - Financial expenses have been a consistent issue, with negative average net cash flow from operating activities over the past three years [3]

Group 1 - The core viewpoint of the article highlights the financial performance of ST Tianrui, indicating a significant decline in revenue and a negative net profit for the first half of 2025 [1] - The total operating revenue for the reporting period was 295 million, a year-on-year decrease of 22.36%, while the net profit attributable to shareholders was -9.58 million, an increase of 35.63% year-on-year [1] - In Q2, the operating revenue was 166 million, down 31.63% year-on-year, and the net profit attributable to shareholders was -12.75 million, a decline of 98.85% year-on-year [1] Group 2 - The company reported a gross margin of 44.76%, which is an increase of 10.44% year-on-year, while the net margin was -6.55%, a decrease of 83.28% year-on-year [1] - Total selling, administrative, and financial expenses amounted to 85.69 million, accounting for 29.07% of revenue, which is an increase of 13.52% year-on-year [1] - The earnings per share was -0.02, an increase of 35.67% year-on-year, while the operating cash flow per share was 0.14, an increase of 232.41% year-on-year [1] Group 3 - The company has a significant amount of accounts receivable, with accounts receivable accounting for 53.46% of the latest annual revenue [1] - Historical data shows that the company's median ROIC over the past 10 years is 0.98%, indicating weak investment returns, with the worst year being 2024 at -5.33% [3] - The company relies heavily on marketing-driven performance, necessitating a thorough examination of the underlying factors driving this performance [3]

Group 1 - ST Tianrui (SZ 300165) held its 16th meeting of the 6th board of directors on August 25, 2025, to review the 2025 semi-annual report and its summary [1] - For the year 2024, ST Tianrui's revenue composition is as follows: Instrument manufacturing accounts for 64.21%, ecological protection and environmental governance accounts for 23.45%, third-party testing services account for 10.42%, and pharmaceutical manufacturing accounts for 1.91% [1] Group 2 - The pet industry is experiencing a significant boom, with a market size of 300 billion yuan, leading to a surge in stock prices of related listed companies [1]

Core Viewpoint - Jiangsu Tianrui Instrument Co., Ltd. has revised its articles of association to enhance corporate governance and clarify the rights and responsibilities of shareholders and management [1] Shareholder Rights and Corporate Governance Improvement - The revised articles emphasize the protection of the legal rights of the company, shareholders, employees, and creditors, based on relevant laws and regulations [2] - New provisions regarding the legal representative of the company have been added, specifying that the chairman of the board serves as the legal representative, with clear procedures for appointment and resignation [2] - Shareholder rights and obligations have been further detailed, providing clearer guidelines for accessing company information [2] Share Issuance and Capital Operations Adjustment - The principle of share issuance has been changed from "same type" to "same category," with the total number of shares specified as 495,511,725, all of which are ordinary shares in RMB [3] - The regulations regarding financial assistance for acquiring shares have been revised, allowing the company to provide financial assistance up to 10% of the total issued share capital, subject to board approval [3] Changes in Shareholder and Board Authority - Significant adjustments have been made to the powers of the shareholder meeting and the board of directors, with the term "shareholders' meeting" standardized to "shareholder meeting" [4] - The board's authority over external investments and asset acquisitions has been clarified, with specific requirements for reviewing and disclosing different types of transactions [4] Detailed Regulations for Directors and Senior Management - The qualifications and obligations of directors and senior management have been specified more rigorously, including conditions under which individuals cannot serve as directors [5] - Directors are required to fulfill multiple duties of loyalty and diligence, with any income from violations reverting to the company, and they are liable for any losses incurred [5] Other Important Amendments - The profit distribution policy emphasizes continuity and stability while balancing the interests of all parties, with detailed procedures for adjusting profit distribution [6] - New provisions regarding internal auditing have been introduced, outlining the responsibilities and workflow of the internal audit department, with the audit committee playing a crucial role [6] - Regulations concerning company mergers, divisions, dissolutions, and liquidations have also been improved [6]